Author

Shoma Chikamatsu

Institution: Kumamoto University

Observed institution: Kumamoto University

OpenAlex ID: A5067196943

Oral Coadministration of Zn-Insulin with d -Form Small Intestine-Permeable Cyclic Peptide Enhances Its Blood Glucose-Lowering Effect in Mice

2021 · Shingo Ito, Yuta Torii, et al. · Molecular Pharmaceutics · 21

Stage- and Region-Dependent Proteomic Alterations in a Mouse Model of Creatine Transporter Deficiency

2026 · Shingo Ito, Yumi Iwata, et al. · Journal of Neuroscience · 1

Effect of Oral Creatine Supplementation on Plasma, Central, and Peripheral Creatine Levels in Creatine Transporter Deficiency Mice

2026 · Naoto Tashiro, Ayaka Miyano, et al. · Pharmaceutical Research

Cyclic SLS Peptide Fusion Enables Efficient Brain Delivery of Monoclonal Antibodies across the Blood−Brain Barrier

2026 · Kanna Kurashiki, Shoei Kameoka, et al. · Molecular Pharmaceutics

Small intestine-permeable cyclic peptide-mediated enhancement of Fc-fusion protein absorption in mice

2026 · Shoma Chikamatsu, Kosei Sakaguchi, et al. · Journal of Pharmaceutical Sciences

Small Intestine-Permeable Cyclic Peptide-Based Technology Enables Efficient Oral Delivery and Glycemic Efficacy of Zinc-Stabilized Insulin Hexamer and Its Analogs in Diabetic Mice

2025 · Shoma Chikamatsu, Kosei Sakaguchi, et al. · Molecular Pharmaceutics

Blood glucose control via oral Zn-insulin administration together with small intestine-permeable cyclic peptides in mouse models of diabetes mellitus

2025 · Shoma Chikamatsu, Kosei Sakaguchi, et al. · Drug Metabolism and Pharmacokinetics

Works count: 7

Citation count: 22

H-index: 1

I10-index: 1